May 21 (Bloomberg) -- Fresenius SE said it obtained $6.1
billion of short-term loans to fund its bid for Rhoen Klinikum
AG, cementing its position as Germany’s biggest operator of
private hospitals.

The so-called bridge financing, which includes a 3.1
billion-euro ($3.96 billion) tranche and a $2.15 billion
portion, will be refinanced with long-term debt that includes
high-yield bonds and loans, Bad Homburg, Germany-based Fresenius
said in an offer document on its website.

The long-term debt will include 700 million euros and $200
million in facility A, 500 million euros and $1.2 billion in
facility B, and a 400 million-euro revolving credit, all of
which will have maturities between five and seven years,
according to the filing. There will also be 1.5 billion euros
and $750 million of a high-yield bridge facility that can be
extended to seven years if it is not refinanced with senior
bonds within the first year, Fresenius said.

Fresenius set a June 27 deadline for Rhoen Klinikum
investors to tender their shares in its 3.1 billion-euro bid to
buy the German hospital operator. The nation’s financial
regulator approved the offer on May 18.

Fresenius completed a 1 billion-euro capital increase on
May 11 to help finance the deal, which will build annual revenue
at the company’s hospital unit to 6 billion euros, about 8
percent of the German market.